The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis
According to a story from Financial Buzz, the pharmaceutical company Proteostasis Therapeutics recently announced that the company's experimental treatment PTI-428 was granted Orphan Drug Designation by the FDA. PTI-428 is…